alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › delivery

delivery

6 studies tagged delivery, dated 2011-11-07 to 2026-10-09. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Organizing healthcare delivery in the era of disease-modifying therapies for Alzheimer's Disease: an Italian RAND/UCLA consensus 2026-10-09
  2. Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor 2024-06-28
  3. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model 2022-12-27

Studies

6 studies carry this tag.

Date range

2011 to 2026

Top journals

  • Advanced drug delivery reviews 1
  • Frontiers in neuroscience 1
  • Medicines (Basel, Switzerland) 1
  • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 1
  • Science (New York, N.Y.) 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Organizing healthcare delivery in the era of disease-modifying therapies for Alzheimer's Disease: an Italian RAND/UCLA consensus

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026-10-09 Treatments

    This consensus provides a pragmatic framework to support the reorganisation of AD care in Italy, ensuring that every patient is directed to the most appropriate level of care across a flexible regional network.

  2. Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Science (New York, N.Y.) 2024-06-28 Genetics

    Prion disease is caused by misfolding of the prion protein (PrP) into pathogenic self-propagating conformations, leading to rapid-onset dementia and death.

  3. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Translational neurodegeneration 2022-12-27 Treatments

    The enhanced delivery of a low dose of Adu (3 mg/kg) via FUS decreases amyloid deposits and attenuates cognitive function deficits.

  4. Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in neuroscience 2020-06-09 Tau biomarkers

    Central nervous system (CNS) disorders especially neurodegenerative disorders are the major challenge for public health and demand the great attention of researchers to protect people against them.

  5. Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Medicines (Basel, Switzerland) 2018-11-23 Treatments

    Neurodegenerative diseases have become a major challenge for public health because of their incurable status.

  6. Nanotechnological advances for the delivery of CNS therapeutics

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Advanced drug delivery reviews 2011-11-07 Tau biomarkers

    Effective non-invasive treatment of neurological diseases is often limited by the poor access of therapeutic agents into the central nervous system (CNS).

All topic tags with their study counts